Cost and healthcare utilization in relapsed/refractory diffuse large B-cell lymphoma: A real-world analysis of Medicare beneficiaries receiving chimeric antigen receptor T-cell vs. autologous and allogeneic hematopoietic cell transplants Meeting Abstract


Authors: Mohammadi, I.; Purdum, A. G.; Wong, A. C.; Schroeder, A.; Kilgore, K. M.; Shah, G. L.
Abstract Title: Cost and healthcare utilization in relapsed/refractory diffuse large B-cell lymphoma: A real-world analysis of Medicare beneficiaries receiving chimeric antigen receptor T-cell vs. autologous and allogeneic hematopoietic cell transplants
Meeting Title: 62nd Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 136
Issue: Suppl. 1
Meeting Dates: 2020 Dec 5-8
Meeting Location: Virtual
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2020-11-05
Language: English
ACCESSION: WOS:000607547205207
DOI: 10.1182/blood-2020-134828
PROVIDER: wos
Notes: Meeting Abstract: 4 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gunjan Lalitchandra Shah
    447 Shah